AMRN Q4 2024 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$62M-17.3% YoY

Gross Profit

-$10M-15.4% margin

Operating Income

-$53M-84.3% margin

Net Income

-$49M-78.0% margin

EPS (Diluted)

$-2.37

QoQ Revenue Growth

+47.3%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$685M

Total Liabilities

$199M

Stockholders' Equity

$486M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$75M	-17.3%
Gross Profit	-$10M	$45M	-121.4%
Operating Income	-$53M	-$5M	-1030.0%
Net Income	-$49M	-$6M	-733.7%

Revenue Segments

Product

$60M96%

Licensing And Royalty

$2M4%